Interfaith Center on Corporate Responsibility - new report on pharmaceutical firms' responses to AIDS
In August 2006, the Interfaith Center on Corporate Responsibility (ICCR) issued a report, "Benchmarking AIDS: Evaluating pharmaceutical company responses to the public health crisis in emerging markets". A PowerPoint summary of the report, which includes scores and "bottom line" assessment of each company, is available here. The Business & Human Rights Resource Centre invited the 15 benchmarked companies to respond to the report; the results to date are indicated below. Below the companies' responses are rejoinders by ICCR and Physicians for Social Justice (Nigeria) to the companies' responses, and a November 2006 follow-up report by ICCR.
COMPANY RESPONSES / NON-RESPONSES:
Abbott Laboratories statement [DOC]
Boehringer-Ingelheim response [DOC]
Bristol-Myers Squibb response [DOC]
Eli Lilly - declined to respond
Gilead Sciences - declined to respond
GlaxoSmithKline response [DOC]
Hoffman-La Roche - declined to respond
sanofi-aventis - declined to respond
Schering-Plough - declined to respond
Tibotec (part of Johnson & Johnson) response [DOC]
Wyeth - press release sent in response to ICCR report
REJOINDERS:
ICCR statement regarding the company responses (6 Nov 2006) [DOC]
Physicians for Social Justice (Nigeria) rejoinder to the company responses [DOC]
- Novartis response to Physicians for Social Justice [DOC]
NOV 2006 ICCR UPDATE:
Benchmarking AIDS: 2006 Year End Update [PDF]
- includes recent steps taken by Abbott, Gilead, GlaxoSmithKline, Novartis, Roche & recommendations for next steps for each of these companies